- Home
- BYFC vs TARA Comparison
BYFC vs TARA Comparison
Compare BYFC & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- TARA
- Stock Information
- Founded
- BYFC 1946
- TARA N/A
- Country
- BYFC United States
- TARA United States
- Employees
- BYFC N/A
- TARA N/A
- Industry
- BYFC Savings Institutions
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BYFC Finance
- TARA Health Care
- Exchange
- BYFC Nasdaq
- TARA Nasdaq
- Market Cap
- BYFC 64.1M
- TARA 52.4M
- IPO Year
- BYFC 1996
- TARA N/A
- Fundamental
- Price
- BYFC $6.97
- TARA $5.16
- Analyst Decision
- BYFC
- TARA Strong Buy
- Analyst Count
- BYFC 0
- TARA 3
- Target Price
- BYFC N/A
- TARA $22.67
- AVG Volume (30 Days)
- BYFC 6.8K
- TARA 6.6M
- Earning Date
- BYFC 10-29-2024
- TARA 11-12-2024
- Dividend Yield
- BYFC N/A
- TARA N/A
- EPS Growth
- BYFC N/A
- TARA N/A
- EPS
- BYFC 0.28
- TARA N/A
- Revenue
- BYFC $35,113,000.00
- TARA N/A
- Revenue This Year
- BYFC N/A
- TARA N/A
- Revenue Next Year
- BYFC N/A
- TARA N/A
- P/E Ratio
- BYFC $24.76
- TARA N/A
- Revenue Growth
- BYFC 12.14
- TARA N/A
- 52 Week Low
- BYFC $4.41
- TARA $1.60
- 52 Week High
- BYFC $7.99
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- BYFC 48.35
- TARA 60.39
- Support Level
- BYFC $7.01
- TARA $5.27
- Resistance Level
- BYFC $7.24
- TARA $6.39
- Average True Range (ATR)
- BYFC 0.15
- TARA 0.91
- MACD
- BYFC -0.02
- TARA 0.03
- Stochastic Oscillator
- BYFC 15.71
- TARA 33.50
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).